Vivozon Pharmaceutical Co., Ltd. (KOSDAQ:082800)
South Korea · Delayed Price · Currency is KRW 4,575.00
+105.00 (2.35%)
At close: Feb 6, 2026
Vivozon Pharmaceutical Market Cap
Vivozon Pharmaceutical has a market cap or net worth of 226.69 billion as of February 6, 2026. Its market cap has decreased by -40.07% in one year.
Market Cap
226.69B
Enterprise Value
260.65B
Revenue
66.40B
Ranking
n/a
PE Ratio
n/a
Stock Price
4,575.00
Market Cap Chart
Since November 18, 2005, Vivozon Pharmaceutical's market cap has increased from 72.45B to 226.69B, an increase of 212.89%. That is a compound annual growth rate of 5.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 226.69B | 12.96% |
| Dec 30, 2025 | 200.68B | -40.93% |
| Dec 30, 2024 | 339.73B | 134.89% |
| Dec 28, 2023 | 144.64B | -2.99% |
| Dec 29, 2022 | 149.09B | -19.87% |
| Dec 30, 2021 | 186.05B | -37.31% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CellBion | 324.00B |
| DAE HWA Pharmaceutical | 264.85B |
| NOVAREX | 253.85B |
| Organoidsciences | 193.61B |
| GREEN CROSS WellBeing | 167.69B |
| Kyung Dong Pharmaceutical | 149.80B |
| PHARMARESEARCH BIO | 144.03B |
| High Tech Pharm | 136.85B |